IRON RX

IRON RX: Telemedicine Focused on Longevity and Performance

IRON RX is an online healthcare platform that offers peptide treatments, weight management programs, and men's performance therapies. Its approach is built around longevity, understood as the ability to influence aging through personalized decisions and care. The company presents itself as a longevity platform that aims to simplify improving current well-being and future health with plans tailored to each individual.

Care Model and Clinical Team

The service relies on an in-house team of US-licensed clinicians who, according to the company, have more than 199 years of combined clinical experience. Care is entirely online, with no in-person visits required. The process begins with a clinical evaluation that reviews the patient's medical history, goals, and risk factors. From there, a personalized plan is defined. The company states that it does not outsource any function: the clinical, customer service, and research teams are all in-house.

The company also notes that prescription products require an online evaluation with a licensed medical professional, who determines whether the prescription is appropriate. Some products are compounded by a US-licensed partner pharmacy with LegitScript certification, according to the company's own information.

Treatments and Products in the Catalog

The visible catalog includes injectable and topical treatments, with starting monthly prices. These include:

• Tirzepatide Injections: a dual-action GLP-1/GIP treatment designed to support appetite regulation, steadier blood sugar, and sustained weight loss, with supervision from a licensed clinician. Starting at $149 per month.
• BPC-157 Injection: a peptide associated with recovery. The company emphasizes that a licensed clinician reviews your case first and provides an evidence-based perspective rather than forum information. Starting at $149 per month.
• BPC-157/TB-500 (Wolverine): a marketed blend of BPC-157 and TB-500. The company warns that neither is FDA approved, that no controlled human trials have tested the combination, and that the only direct controlled comparison is a small rat study. Starting at $179 per month.
• CJC-1295/Ipamorelin Injection: synthetic growth hormone secretagogues. The company notes that neither is FDA approved and that human evidence mainly concerns CJC-1295 with DAC and hormone levels, not recovery, body composition, or performance outcomes. Starting at $249 per month.
• GHK-Cu Skin Cream: a topical copper peptide cream formulated to support smoother, firmer-looking skin by encouraging the repair and renewal processes that slow down with age. Starting at $179 per month.
• NAD+ Injection - 1000 mg: a high-dose injection designed to support cellular energy, mental clarity, and healthy aging at the mitochondrial level. Starting at $220 per month.
• Sermorelin Injection - Low Dose: supports energy, lean muscle, and strength by encouraging your body to gradually replenish its own growth hormone—without the risks of synthetic HGH. Starting at $149 per month.
• Cruise Control - 30 Tablets: a daily performance tablet designed to support stamina, confidence, and consistent performance without the wait. Starting at $69 per month.

The company also mentions other treatment categories such as NAD+, glutathione, peptides, and GLP-1, and organizes its offerings by health goals: longevity, weight management, energy and focus, pain and inflammation, sleep, skin, hair, and sexual health.

Purchase Process and Logistics

The patient journey is described in three steps. First, a consultation with a US-licensed medical provider, entirely online. Second, if treatment is approved, it is compounded through a licensed partner pharmacy with LegitScript certification, rigorously inspected, and shipped discreetly to your home. Third, the patient receives ongoing support: unlimited messaging with the care team, easy refills, unlimited dosage adjustments, and access to more than 40 science-backed plans.

Customer Service and Reported Results

The company states that its customer service team is fully in-house and that questions are not treated as tickets to close, but as problems to solve. According to its data, the average response time is under 24 hours, average member satisfaction is 4.75 out of 5, and 97% of inquiries are resolved in a single interaction. It also indicates that 82% of people notice at least one benefit at their first review, based on a self-reported survey of 162 customers who consulted with their provider at that first review.

Medical Team and Educational Content

The medical review team includes Naheed Ali, MD, PhD, ScD, a physician and health author focused on metabolic health, weight management, and evidence-based lifestyle medicine, with training from the College of Natural Health, Xavier University School of Medicine, and Adelphi University. The team also includes Dr. Reza Omid, MD, MPH, a physician and researcher in prostate cancer and research partnerships advisor at BCARAS, specializing in urology, androgen pathway pharmacology, and hormone-targeted therapies, with training from Tehran University of Medical Sciences, Prince Sattam University, and Mount Sinai Medical Center, Urology.

The company maintains a blog with content on peptide science and patient guides. Visible articles include one on who is a suitable candidate for GHK-Cu therapy, another on why CJC-1295 and Ipamorelin are combined instead of using each peptide separately, and a guide on the shelf life of BPC-157 before and after reconstitution. It also publishes content on whether NAD+ requires a prescription and on oral versus injectable semaglutide.

Regulatory Disclaimers and Scope of Service

The company includes a disclaimer stating that statements about its products have not been evaluated by the FDA and that they are not intended to diagnose, treat, cure, or prevent any disease. Prescription products require an online evaluation with a licensed medical professional to determine whether the prescription is appropriate. Some products are compounded by a licensed pharmacy, and the FDA has not reviewed or approved compounded products for any use in terms of safety, efficacy, or quality. The benefits indicated on the site are based on third-party studies. Medication is offered as a subscription service cancelable at any time. The company also warns that the actual product packaging may differ from what is shown.

IRON RX states that more than 15,000 people use its services and offers an initial questionnaire to guide interested parties. Its offering is presented as a subscription service with plans starting at the monthly prices listed in the catalog.